33.6 C
Singapore
Tuesday, July 7, 2020
- Advertisement -

FDA approves a COVID-19 home testing kit from LabCorp

|

|

Reading time: 2 min read

|

|

Reading time: 2 min read

LabCorp‘s at home COVID-19 RT-PCR test becomes the first home testing kit for the disease to be approved by the FDA. This test kit provides a sample of collection materials that includes the nasal swab to the user, who later uses the included package to return the sample to the lab for testing.

FDA had not authorized any at-home testing or sample collection kits until now. It notes that testing kits by startup companies that were not authorized did not follow the guideline that they had laid out.

Some labs around the world have been providing at-home serology tests, but they are not viewed as tests that can confirm COVID-19 by the FDA. Opening up home testing even if it is just sample collection is a huge step of change in the way the FDA has been handling things.

The agency recently updated its guidelines and noted that it is working with at-home test providers to come up with the best way to make these kits available to the public as it “sees the public health value in expanding the availability of COVID-19 testing through safe and accurate tests that may include home collection.”

LabCorp is a medical diagnostics company based in the US that has experience of more than 40 years. It has provided at-home testing via its Pixel line for diabetes, cardiac lipid conditions, and cancer. From what it looks like, it seems like the FDA is favoring LabCorp’s long-standing experience in terms of opening up for at-home collection for COVID-19 and ensuring that the tests are accurate.

Testing for COVID-19 currently relies on in-clinic, hospital, and drive-through sites testing. The tests have a high bar in terms of symptom presentation and risk profile, and this administration exposes healthcare workers to COVID-19, and they might as well get infected.

At-home testing could drastically increase overall testing in the country and decrease the risk for healthcare professionals in the process. It will also help paint a better picture of the true depth and extent of the COVID-19 pandemic.

- Advertisement -
Simon Cohen
Simon Cohen
America | Simon Cohen is native New Yorker and a fan of all things tech. Apart from writing about tech, Simon spends his time in the music studio as a producer.
- Advertisement -

People also Reading

How ShopBack Enables Better Savings with Cashback and Online Shopping Offers

When e-commerce first took off in the region five years ago, merchants were following a standard formula which would lead to reasonable success: build...

The COVID-19 pandemic has made your VPN even more invaluable

During the pandemic, most institutions and companies have been working from home. There are many secure platforms to use, but there are...

WhatsApp new limit cuts ‘highly forwarded’ messages by 70%

In its fight to stop misinformation, WhatsApp introduced a new limit for highly forwarded messages earlier this month, and the limit is...
- Advertisement -
Send this to a friend